LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Recruiting · NCT06018766 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. | Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-05-18 | NCT06018766 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| IRulya Therapeutics Inc. | 2 |
| Steven Hays, MD | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California, San Francisco | San Francisco | United States | 294 |